Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

NCT07736937 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: TUB-040 + Carbo + BEV

Sponsor

Gilead Sciences